Evidence map›Paper›PMID 40225169›Full record

ArticleHuman mutation2023

The Broad Spectrum of

Grégory Lazarian, Bernard Leroy, Floriane Theves, Myriam Hormi, Rémi Letestu, Virginie Eclache, Giulia Tueur, Adam Ameur, Audrey Bidet, Pascale Cornillet-Lefebvre and 19 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human mutation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. ComplexInternational journal of molecular sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Grégory LazarianService d'Hématologie Biologique, Hopital Avicenne, Hopitaux Universitaire de Paris Seine Saint Denis, Assistance Publique Hopitaux de Paris, Bobigny, France.
Bernard LeroySorbonne Université, Place Jussieu, 75005 Paris, France.
Floriane ThevesService d'Hématologie Biologique, CHU Pitié Salpêtrière, Paris 75013, France.
Myriam HormiService d'Hématologie Biologique, Hopital Avicenne, Hopitaux Universitaire de Paris Seine Saint Denis, Assistance Publique Hopitaux de Paris, Bobigny, France.
Rémi LetestuService d'Hématologie Biologique, Hopital Avicenne, Hopitaux Universitaire de Paris Seine Saint Denis, Assistance Publique Hopitaux de Paris, Bobigny, France.
Virginie EclacheService d'Hématologie Biologique, Hopital Avicenne, Hopitaux Universitaire de Paris Seine Saint Denis, Assistance Publique Hopitaux de Paris, Bobigny, France.
Giulia TueurService d'Hématologie Biologique, Hopital Avicenne, Hopitaux Universitaire de Paris Seine Saint Denis, Assistance Publique Hopitaux de Paris, Bobigny, France.
Adam AmeurScience for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-6085-6749
Audrey BidetService d'Hématologie Biologique, CHU Bordeaux-Haut Lévêque, Bordeaux 33000, France.
Pascale Cornillet-LefebvreService d'Hématologie Biologique, CHU Hôpital Robert Debré, Reims 51100, France.
Frédéric DaviService d'Hématologie Biologique, CHU Pitié Salpêtrière, Paris 75013, France.
Eric DelabesseLaboratoire d'Hématologie, CHU Toulouse, Inserm 1037, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.
Marie-Hélène EstienneService d'Hématologie Biologique, CHRU Tours, Tours 37044, France.
Pascaline EtancelinLaboratoire de Génétique Oncologique, Département de Biopathologie, Centre Henri Becquerel, 76038 Rouen, France.
Olivier KosmiderService d'Hématologie Biologique, CHU Hôpital Cochin, Paris 75014, France.
Sophy LaibeXPath Cytogénétique et Biologie Moléculaire, Marseilles 13010, France.
Marc MullerLaboratoire de Génétique Médicale, CHRU Nancy-Hôpitaux de Brabois, Vandoeuvre-Lès-Nancy, 54511, France.
Nathalie NadalService de Génétique Chromosomique et Moléculaire, CHU Dijon, Dijon 21000, France.
Dina NaguibService d'Hématologie Biologique, CHU Caen, Caen 14033, France.
Cédric PastoretService d'Hématologie Biologique, CHU Rennes, Rennes 35000, France.
Stéphanie PoulainService d'Hématologie Cellulaire, CHRU Lille, Lille 59000, France.
Pierre SujobertService d'Hématologie Cellulaire, Hospices Civils de Lyon, Lyon 69002, France.
Lauren VeroneseService de Cytogénétique Médicale, CHU Clermont-Ferrand, Clermont-Ferrand 63000, France.
Samia ImacheService d'Hématologie Biologique, Hopital Avicenne, Hopitaux Universitaire de Paris Seine Saint Denis, Assistance Publique Hopitaux de Paris, Bobigny, France.
Valérie LefebvreService d'Hématologie Biologique, Hopital Avicenne, Hopitaux Universitaire de Paris Seine Saint Denis, Assistance Publique Hopitaux de Paris, Bobigny, France.
Florence CymbalistaService d'Hématologie Biologique, Hopital Avicenne, Hopitaux Universitaire de Paris Seine Saint Denis, Assistance Publique Hopitaux de Paris, Bobigny, France.
Fanny Baran-MarszakService d'Hématologie Biologique, Hopital Avicenne, Hopitaux Universitaire de Paris Seine Saint Denis, Assistance Publique Hopitaux de Paris, Bobigny, France.ORCID 0000-0002-3723-2927
Thierry SoussiSorbonne Université, Place Jussieu, 75005 Paris, France.ORCID 0000-0001-8184-3293
French Innovative Leukemia Organization (FILO)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Lymphocytic, Chronic, B-CellMutationTumor Suppressor Protein p53HumansTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID40225169
PMCPMC11918887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.